SKI Market

Indian Indices

Sensex

84,559.65 -120.21
( -0.14%)

Global Indices

Nasdaq

47,912.86 -222.41
(-0.46%)

Dow Jones

6,743.36 -77.90
(-1.14%)

Hang Seng

49,518.65 135.36
(0.27%)

Nikkei 225

9,795.97 111.18
(1.15%)

Forex

USD-INR

90.68 0.14
(0.16%)

EUR-INR

106.49 0.21
(0.20%)

GBP-INR

121.26 0.23
(0.19%)

JPY-INR

0.58 0.00
(0.55%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

124.06

27.69

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

Nagreeka Exports standalone net profit declines 3.54% in the September 2025 quarter

Nov 15,2025

Net profit of Nagreeka Exports declined 3.54% to Rs 1.09 crore in the quarter ended September 2025 as against Rs 1.13 crore during the previous quarter ended September 2024. Sales declined 10.21% to Rs 123.00 crore in the quarter ended September 2025 as against Rs 136.98 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	123.00	136.98	-10
OPM %	4.69	4.27	-
PBDT	2.90	3.19	-9
PBT	1.15	1.40	-18
NP	1.09	1.13	-4

84,559.65 -120.21 ( -0.14%)

47,912.86 -222.41 (-0.46%)

6,743.36 -77.90 (-1.14%)

49,518.65 135.36 (0.27%)

9,795.97 111.18 (1.15%)

90.68 0.14 (0.16%)

106.49 0.21 (0.20%)

121.26 0.23 (0.19%)

0.58 0.00 (0.55%)